What does DOYEN BENOIT CARDIOLOGIE do?

DOYEN BENOIT CARDIOLOGIE is a specialist medical practice in Namur. Private Limited, started on 5 February 2021.

What is the address of DOYEN BENOIT CARDIOLOGIE?

The registered office of DOYEN BENOIT CARDIOLOGIE is located at Chemin des Ajoncs(WP) 16, 5100 Namur.

Is DOYEN BENOIT CARDIOLOGIE still active?

Yes. According to the CBE (2 October 2026) DOYEN BENOIT CARDIOLOGIE is active, legal situation “Normale toestand”, started on 5 February 2021.

Is DOYEN BENOIT CARDIOLOGIE registered on Peppol?

Yes, DOYEN BENOIT CARDIOLOGIE is registered on the Peppol network with ID 0208:0762967851.

What is the enterprise number of DOYEN BENOIT CARDIOLOGIE?

The enterprise number of DOYEN BENOIT CARDIOLOGIE is BE0762967851.

When was DOYEN BENOIT CARDIOLOGIE founded?

DOYEN BENOIT CARDIOLOGIE was founded on 5 February 2021.

Who are the directors of DOYEN BENOIT CARDIOLOGIE?

According to the 2025 annual accounts, the directors of DOYEN BENOIT CARDIOLOGIE are: BENOIT DOYEN.

Is DOYEN BENOIT CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 February 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOYEN BENOIT CARDIOLOGIE make in 2025?

DOYEN BENOIT CARDIOLOGIE posted a profit after taxes of € 137,832 in financial year 2025.

What is the revenue of DOYEN BENOIT CARDIOLOGIE?

As a small company, DOYEN BENOIT CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 199,516.

DOYEN BENOIT CARDIOLOGIE (Private Limited) - Namur

Dossier DOYEN BENOIT CARDIOLOGIE, printed on 2 October 2026 from databakkes.be/en/0762967851/doyen-benoit-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOYEN BENOIT CARDIOLOGIE from Namur, company number BE0762967851, closed financial year 2025 with a result of € 137,832 after tax. For that financial year DOYEN BENOIT CARDIOLOGIE recorded a gross margin of € 199,516 and equity of € 19,832. Compared with financial year 2024, the result moved from € 137,475 to € 137,832. Profitable, and profit is growing. The buffer shrank hard: equity is 86 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 11, 2026.

What it is worth Shrank hard

€ 19,832

▼ 86% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 137,832

Profit after tax over the fiscal year.

Cash in the bank

€ 119,006

▼ 68% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 255,425 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 4,033

▼ 60% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,830

▲ € 1,709 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,426

▼ 5% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 93,359 Gross margin 2022: € 93,359 First fiscal year in the series	€ 271,894 Gross margin 2023: € 271,894 ▲ 191% vs 2022 (€ 93,359) Favourable step	€ 191,163 Gross margin 2024: € 191,163 ▼ 30% vs 2023 (€ 271,894) Unfavourable step	€ 199,516 Gross margin 2025: € 199,516 ▲ 4% vs 2024 (€ 191,163) Favourable step	▲ 4%
Profit after taxes	€ 63,986 Profit after taxes 2022: € 63,986 First fiscal year in the series	€ 192,545 Profit after taxes 2023: € 192,545 ▲ 201% vs 2022 (€ 63,986) Favourable step	€ 137,475 Profit after taxes 2024: € 137,475 ▼ 29% vs 2023 (€ 192,545) Unfavourable step	€ 137,832 Profit after taxes 2025: € 137,832 Unchanged (€ 137,475) Favourable step
Equity	€ 162,405 Equity 2022: € 162,405 First fiscal year in the series	€ 354,950 Equity 2023: € 354,950 ▲ 119% vs 2022 (€ 162,405) Favourable step	€ 137,425 Equity 2024: € 137,425 ▼ 61% vs 2023 (€ 354,950) Unfavourable step	€ 19,832 Equity 2025: € 19,832 ▼ 86% vs 2024 (€ 137,425) Unfavourable step	▼ 86%
Total debts	€ 45,416 Total debts 2022: € 45,416 First fiscal year in the series	€ 90,435 Total debts 2023: € 90,435 ▲ 99% vs 2022 (€ 45,416) Unfavourable step	€ 384,049 Total debts 2024: € 384,049 ▲ € 293,615 vs 2023 (€ 90,435) Unfavourable step	€ 276,810 Total debts 2025: € 276,810 ▼ 28% vs 2024 (€ 384,049) Favourable step	▼ 28%
Cash	€ 140,123 Cash 2022: € 140,123 First fiscal year in the series	€ 12,382 Cash 2023: € 12,382 ▼ 91% vs 2022 (€ 140,123) Unfavourable step	€ 372,712 Cash 2024: € 372,712 ▲ € 360,330 vs 2023 (€ 12,382) Favourable step	€ 119,006 Cash 2025: € 119,006 ▼ 68% vs 2024 (€ 372,712) Unfavourable step	▼ 68%
Retained profit	€ 160,405 Retained profit 2022: € 160,405 First fiscal year in the series	€ 352,950 Retained profit 2023: € 352,950 ▲ 120% vs 2022 (€ 160,405) Favourable step	€ 135,425 Retained profit 2024: € 135,425 ▼ 62% vs 2023 (€ 352,950) Unfavourable step	€ 17,832 Retained profit 2025: € 17,832 ▼ 87% vs 2024 (€ 135,425) Unfavourable step	▼ 87%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 355,000 Dividend 2024: € 355,000 Unchanged (€ 0) Unchanged	€ 255,425 Dividend 2025: € 255,425 ▼ 28% vs 2024 (€ 355,000) Unchanged	▼ 28%
Balance sheet total	€ 207,821 Balance sheet total 2022: € 207,821 First fiscal year in the series	€ 445,384 Balance sheet total 2023: € 445,384 ▲ 114% vs 2022 (€ 207,821) Unchanged	€ 521,474 Balance sheet total 2024: € 521,474 ▲ 17% vs 2023 (€ 445,384) Unchanged	€ 296,642 Balance sheet total 2025: € 296,642 ▼ 43% vs 2024 (€ 521,474) Unchanged	▼ 43%

Key figures of DOYEN BENOIT CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOYEN BENOIT CARDIOLOGIE?

What happened at DOYEN BENOIT CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 11, 2026 New annual accounts for financial year 2025: profit of € 137,832. filed late Source: NBB ↗
2021 BENOIT DOYEN became a director. NBB
Feb 5, 2021 Start of the company according to the CBE. KBO

In short

From € 63,986 profit in 2022 to € 137,832 profit in 2025.

Paid € 156,235 in corporate taxes since 2022.

Best year ever: 2023, with € 192,545 profit.

Paid out € 610,425 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOYEN BENOIT CARDIOLOGIE? We notify you, reason included.

Follow DOYEN BENOIT CARDIOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

BENOIT DOYEN

DOYEN BENOIT CARDIOLOGIE

Behind DOYEN BENOIT CARDIOLOGIE is BENOIT DOYEN.

See the full network in the app

Directors

According to the 2025 annual accounts

BENOIT DOYEN

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin des Ajoncs(WP) 16

5100 Namur

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0762.967.851
VAT number: BE 0762.967.851
Registered office: Chemin des Ajoncs(WP) 16, 5100 Namur
Names & denominations: DOYEN BENOIT CARDIOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 February 2021
Peppol: Active · Active since 23 Dec 2025
Contact: [email protected]
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗